Cargando…

Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment

Cisplatin (cis-diaminedichloroplatinum-II) is an extensively used chemotherapeutic agent, and one of its most adverse effects is ototoxicity. A number of studies have demonstrated that these effects are related to oxidative stress and DNA damage. However, the precise mechanism underlying cisplatin-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, H-J, Oh, G-S, Shen, A, Lee, S-B, Choe, S-K, Kwon, K-B, Lee, S, Seo, K-S, Kwak, T H, Park, R, So, H-S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611728/ https://www.ncbi.nlm.nih.gov/pubmed/24922076 http://dx.doi.org/10.1038/cddis.2014.255

Ejemplares similares

Augmentation of cellular NAD(+) by NQO1 enzymatic action improves age‐related hearing impairment
por: Kim, Hyung‐Jin, et al.
Publicado: (2019)

Pharmacological activation of NQO1 increases NAD(+) levels and attenuates cisplatin-mediated acute kidney injury in mice
por: Oh, Gi-Su, et al.
Publicado: (2014)

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity
por: Oh, Gi-Su, et al.
Publicado: (2016)

NAD(+) augmentation ameliorates acute pancreatitis through regulation of inflammasome signalling
por: Shen, AiHua, et al.
Publicado: (2017)

Augmentation of NAD(+) by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Lee, Seung Hoon, et al.
Publicado: (2022)

β-lapachone ameliorates murine cisplatin nephrotoxicty – NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation
por: Lu, Christopher Y.
Publicado: (2014)

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.
por: Ross, D., et al.
Publicado: (1996)

Increased Cellular NAD(+) Level through NQO1 Enzymatic Action Has Protective Effects on Bleomycin-Induced Lung Fibrosis in Mice
por: Oh, Gi-Su, et al.
Publicado: (2016)

Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family
por: Vasiliou, Vasilis, et al.
Publicado: (2006)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells
por: Siegel, David, et al.
Publicado: (2012)

A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy
por: Begleiter, Asher, et al.
Publicado: (2009)

Pharmacological stimulation of NQO1 decreases NADPH levels and ameliorates acute pancreatitis in mice
por: Shen, AiHua, et al.
Publicado: (2018)

Aerobic Cytotoxicity of Aromatic N-Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1)
por: Nemeikaitė-Čėnienė, Aušra, et al.
Publicado: (2020)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians
por: Stoehr, Christine G., et al.
Publicado: (2012)

Overexpression of CYB5R3 and NQO1, two NAD (+)‐producing enzymes, mimics aspects of caloric restriction
por: Diaz‐Ruiz, Alberto, et al.
Publicado: (2018)

Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
por: Lee, Chang Ho, et al.
Publicado: (2020)

Attenuates of NAD(+) impair BMSC osteogenesis and fracture repair through OXPHOS
por: Li, Boer, et al.
Publicado: (2022)

Implications of NQO1 in cancer therapy
por: Oh, Eun-Taex, et al.
Publicado: (2015)

NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places
por: Pey, Angel L., et al.
Publicado: (2019)

Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H: quinone oxidoreductase 1 (NQO1)
por: Lienhart, Wolf-Dieter, et al.
Publicado: (2017)

LncRNA Nqo1-AS1 Attenuates Cigarette Smoke-Induced Oxidative Stress by Upregulating its Natural Antisense Transcript Nqo1
por: Zhang, Haiyun, et al.
Publicado: (2021)

Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
por: Nan, Benyu, et al.
Publicado: (2022)

Modulation of Cellular NAD(+) Attenuates Cancer-Associated Hypercoagulability and Thrombosis via the Inhibition of Tissue Factor and Formation of Neutrophil Extracellular Traps
por: Cao, Wa, et al.
Publicado: (2021)

Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome
por: Atiomo, William, et al.
Publicado: (2017)

De-novo NAD(+) synthesis regulates SIRT1-FOXO1 apoptotic pathway in response to NQO1 substrates in lung cancer cells
por: Liu, Huiying, et al.
Publicado: (2016)

Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels
por: Nishida-Tamehiro, Kyoko, et al.
Publicado: (2022)

Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations
por: Menzel, H-J, et al.
Publicado: (2004)

A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
por: Choudry, G A, et al.
Publicado: (2001)

Activation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphane
por: Wu, Joseph M., et al.
Publicado: (2016)

NAD(+) augmentation restores mitophagy and limits accelerated aging in Werner syndrome
por: Fang, Evandro F., et al.
Publicado: (2019)

Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1)
por: Nakamura, Yuko, et al.
Publicado: (2017)

Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression
por: Wang, Jie, et al.
Publicado: (2021)

Redox modulation of NQO1
por: Siegel, David, et al.
Publicado: (2018)

Arylamino-nor-β-lapachone derivative-induced apoptosis in human prostate cancer cells: involvement of NAD(P)H:quinone oxidoreductase (NQO1)
por: Cavalcanti, Bruno C, et al.
Publicado: (2013)

FAD-deficient P187S mutation of NAD(P)H:quinone oxidoreductase 1 (NQO1*2) binds and accelerates β-amyloid aggregation
por: Panja, Sudipta, et al.
Publicado: (2022)

Cimicifugae Rhizoma Extract Attenuates Oxidative Stress and Airway Inflammation via the Upregulation of Nrf2/HO-1/NQO1 and Downregulation of NF-κB Phosphorylation in Ovalbumin-Induced Asthma
por: Lim, Je-Oh, et al.
Publicado: (2021)

Lamin A/C impairments cause mitochondrial dysfunction by attenuating PGC1α and the NAMPT-NAD(+) pathway
por: Maynard, Scott, et al.
Publicado: (2022)

NQO1 regulates cell cycle progression at the G2/M phase
por: Oh, Eun-Taex, et al.
Publicado: (2023)

NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016)

Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD(+) and SIRT1
por: Ghosh, Nandini, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_km15uhiij943vtnpoa7egtj4rh